Education
About Us
Working with TipRanks
Follow Us
Vladislav Sandler Insider Profile
4 Followers
Vladislav Sandler, Chief Executive Officer at HemoGenyx Pharmaceuticals Plc, holds 353.86K shares in HemoGenyx Pharmaceuticals Plc (Ticker: GB:HEMO). Most recently, Vladislav Sandler Bought 250,000p shares of HemoGenyx Pharmaceuticals Plc on May 08, 2025 for an estimated value of 451.25K.
Vladislav Sandler has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Vladislav Sandler's holdings
Insider Roles
Chief Executive Officer
Roles that Vladislav Sandler holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Vladislav Sandler
Vladislav Sandler's Trading History
List of latest transactions for each holding click on a transaction to see Vladislav Sandler's performance on stock
You May Also Like
Vladislav Sandler insider profile FAQ
What is the percentage of profitable transactions made by Vladislav Sandler?
The percentage of profitable transactions made by Vladislav Sandler is ―.
What is the average return per transaction made by Vladislav Sandler?
The average return per transaction made by Vladislav Sandler is ―.
What stocks does Vladislav Sandler hold?
Vladislav Sandler holds: GB:HEMO stocks.
What was Vladislav Sandler’s latest transaction?
Vladislav Sandler latest transaction was an Informative Buy of 451.25K.
What was Vladislav Sandler's most profitable transaction?
Vladislav Sandler’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Vladislav Sandler's role in HemoGenyx Pharmaceuticals Plc?
Vladislav Sandler's role in HemoGenyx Pharmaceuticals Plc is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.